Identifying Skin Conditions Can be a Pain for People of Color. This Instagram Account Can Help
Devanath / Pixabay

Identifying Skin Conditions Can be a Pain for People of Color. This Instagram Account Can Help

According to a story from offspring.lifehacker.com, medical abnormalities and conditions that affect the skin are often something that many of us will notice on our own. Once a skin problem…

Continue Reading Identifying Skin Conditions Can be a Pain for People of Color. This Instagram Account Can Help
After a Childhood Plagued by Illness, This Woman Was Finally Diagnosed With Mitochondrial Disease
jarmoluk / Pixabay

After a Childhood Plagued by Illness, This Woman Was Finally Diagnosed With Mitochondrial Disease

According to a story from Wales Online, Samantha Josey's childhood was characterized by unpleasant symptoms and health problems, resulting in hospital visits and bouts of serious illness. Her symptoms included…

Continue Reading After a Childhood Plagued by Illness, This Woman Was Finally Diagnosed With Mitochondrial Disease
The Center for Chronic Illness’s Support Groups: A Resource for Community and Support for Rare Disease Patients
rawpixel / Pixabay

The Center for Chronic Illness’s Support Groups: A Resource for Community and Support for Rare Disease Patients

The Center for Chronic Illness is a nonprofit group that is based out of Seattle, Washington. The goals of this organization include the provision of support and educational resources to…

Continue Reading The Center for Chronic Illness’s Support Groups: A Resource for Community and Support for Rare Disease Patients
A Potential Treatment for Idiopathic Pulmonary Fibrosis Earns Orphan Drug Designation
Pexels / Pixabay

A Potential Treatment for Idiopathic Pulmonary Fibrosis Earns Orphan Drug Designation

According to a story from Financial Buzz, the biotherapeutics company Bellerophon Therapeutics Inc. has recently announced that it has earned Orphan Drug designation from the US Food and Drug Administration…

Continue Reading A Potential Treatment for Idiopathic Pulmonary Fibrosis Earns Orphan Drug Designation

The Phase 3 Trial in Diabetic Peripheral Neuropathy May Have Failed Due to a Critical Mistake

  FierceBiotech recently reported that Helixmith Co., based in Korea and previously known as ViroMed, coordinated a Phase 3 clinical trial involving five hundred diabetic peripheral neuropathy (DPN) patients. The…

Continue Reading The Phase 3 Trial in Diabetic Peripheral Neuropathy May Have Failed Due to a Critical Mistake